Masimo Corporation (MASI) Financials

MASI Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 1.6 billion 853.8 million
Dec. 31, 2025 1.7 billion 977.7 million
Sept. 30, 2025 1.8 billion 1.0 billion
June 30, 2025 2.4 billion 1.4 billion

MASI Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 40.0 million 8.9 million
Dec. 31, 2025 53.4 million 8.9 million
Sept. 30, 2025 50.9 million 9.3 million
June 30, 2025 64.5 million 8.5 million

MASI Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 56.3 million
Dec. 31, 2025 497.7 million
Sept. 30, 2025 53.7 million
June 30, 2025 44.9 million

MASI Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 124.6 million 445.7 million 25.7 million
Dec. 31, 2025 152.3 million 518.0 million 26.9 million
Sept. 30, 2025 314.7 million 559.1 million 19.4 million
June 30, 2025 149.6 million 598.7 million 28.5 million

MASI Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 52.6 million
Dec. 31, 2025 54.2 million
Sept. 30, 2025 54.4 million
June 30, 2025 54.8 million

MASI Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 5.3 million 30.0 million 143.4 million -
Dec. 31, 2025 7.1 million 32.1 million 131.3 million -
Sept. 30, 2025 5.9 million 30.5 million 116.4 million -
June 30, 2025 4.9 million 29.9 million 138.9 million -

MASI Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 403.6 million 152.8 million
Dec. 31, 2025 412.5 million 165.2 million
Sept. 30, 2025 371.5 million 140.9 million
June 30, 2025 370.9 million 137.6 million

MASI Revenue by Segment

Graph available only for paid members. Upgrade to see it.

MASI

Price: $179.95

52 week price:
125.94
179.95

Payout Ratio Range:
-2.45%
439.93%

Earnings Per Share: 4.05 USD

P/E Ratio: 44.03

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 139670

Ebitda: 52.9 million

Market Capitalization: 9.4 billion

Links: